Other Related

Events

Views Navigation

Event Views Navigation

Today

  • Virtual Psychiatry Grand Rounds – Marley Doyle, MD

    Marley Doyle, MD talk title TBA   Zoom link Meeting ID: 948 0596 9836 Passcode: 5555   CME Credit information Those viewing Grand Rounds are now responsible for logging their […]

  • Contingency Management, HIV, and MSM: Current Status

    Our #VCBHLectureSeries is back! We are thrilled to kick off the FY23 season with guest speaker, Steven Shoptaw, PhD, Executive Director of the Center for Behavioral and Addiction Medicine at UCLA. He […]

  • What has Brain Imaging Taught us about Addiction?

    Edythe London, PhD will be joining us to discuss how the imaging of brain structure, chemistry and function is possible using noninvasive techniques that have been applied to the study […]

  • The Neurobiology of Addiction

    Presenter: Steven Straubing, MD Cost: No fee Target Audience: This activity was developed to meet the needs of physicians and all interprofessional healthcare providers. This discussion is designed to promote […]

  • Tobacco Regulations Across the Continuum of Harm

    Tracy Smith, PhD Assistant Professor of Psychiatry and Behavioral Services Medical University of South Carolina   The VCBH Monthly Lecture Series was originally created as an in-person series designed as […]

  • Alcohol Use Disorder (FAME Session #3)

    Presenters: Abby Letcher, MD, FASAM; Angela Colistra, PhD, LPC, CAADC, CCS; Shanna Diaz, DO Series: This 2-hour, virtual-live session is part of the FAME 8-session series and will cover overdose prevention […]

  • The Connection Between Mental Health and Opioid Use Disorder

    Presenter: Mark Duncan, MD, Assistant Professor, University of Washington, Director, UW Psychiatry and Addictions Case Conference Sponsor: American Psychiatric Association (APA) Cost: No Fee Target audience: Physicians, nurse practitioners or other advanced […]

  • Screening for Substance Use in Primary Care: Screening Tools and Guidance for Implementation

    Presenter: Jennifer McNeely, MD Sponsor: American Psychiatric Association (APA) and American Academy of Addiction Psychiatry (AAAP) Cost: No Fee Target audience: Physicians, psychologists, social workers, physician assistants, pharmacists, interprofessional team, residents/fellows, medical students, other mental health clinicians Credit Designations Available: AMA PRA Category 1 Credit™, AAPA Category 1 CME, Social Work CE Credit, Nursing Contact Hours, Pharmacy […]

  • Substance Use Disorders in Late Life

    Register Now   Presenters: Roberto D. Sanchez, DO and Ali Abbas Asghar-Ali, MD Target Audience: This activity is designed for Psychiatrists, Physicians, Physician Assistants, Nurses/Nurse Practitioners, Social Workers, Psychologists, Pharmacists, other mental health clinicians working within addiction. This activity is accredited for Physicians, Physician Assistants, Social Workers, Pharmacists, and Healthcare teams. Credit Designations Available: AMA […]

  • How Adding a Clinical Pharmacist Improves Access to Addiction Care

    Register here Presenters: Ben Miskle, PharmD, University of Iowa Hospitals and Clinics Alison Lynch, MD, MS, University of Iowa Hospitals and Clinics Sponsor: American Academy of Addiction Psychiatry (AAAP) Cost: No Fee Target audience: Physicians, nurse practitioners or other advanced practice nurses, PAs, social workers, and pharmacists Credit designations available: Pharmacy CE Credit, AMA PRA Category 1 […]

  • Nurses’ Practices with People Experiencing Opioid Use Disorder

    Register Now   Presenter: Timothy J. Sowicz, PhD, RN Cost: No Fee Target audience: This activity is designed for for Nurses, MAT Team Providers, Addictions Specialists, SUD Project Directors, Managers, and Facilitators. This activity is accredited for nurses. Credit Designations Available: Nursing CE Webinar description: The purpose of this presentation is to present the findings from a narrative literature […]

  • Co-occurring Opioid and Stimulant Use Disorders: Treatment and Management Approaches

    Register Now Presenters: Jonathan Craig Allen, MD, FASAM, and Marc Fishman, MD Sponsor: National Council for Mental Wellbeing--NCMW Continuing education information: AMA PRA Category 1 Credit™, Nursing Contact Hours, AAPA Category 1 CME credit, SW CE credit, Pharmacy CE credit and IPCE credit Target Audience: This activity is designed for physicians, nurses, PAs, pharmacists, social […]

  • Treatment Considerations in the Age of Fentanyl

    Fentanyl and other high-potency synthetic opioids are increasingly present in the U.S. drug supply. Healthcare systems, treatment providers, and justice systems are grappling with the physiological consequences of chronic fentanyl use and how its use may impact treatment. Speakers: - Kathryn Cates-Wessel, CEO, American Academy of Addiction Psychiatry - John J. Mariani, MD, Associate Professor […]

  • Mindfulness-Oriented Recovery Enhancement: Clinical Outcomes and Biobehavioral Mechanisms of an Evidence-Based Therapy for Chronic Pain, Opioid Misuse, and Opioid Use Disorder

    Register Now   Presenter: Eric Garland, PhD, LCSW Sponsoring organization: American Society for Pain Management Nursing (ASPMN) Target audience: Clinical providers including Physicians, PAs and NPs About the webinar: Half of all people with a substance use disorder (SUD) have chronic pain, and more than a third have a co-occurring psychiatric disorder. The ongoing opioid crisis is a […]

  • Initiating Buprenorphine for Patients Using Fentanyl

    Register Now Presenter: Brian Hurley, MD, MBA, DFASAM, FAPA Cost: No Fee Target audience: Nurses, Addictions Specialists, SUD Project Directors, Managers, and Facilitators and MOUD (medications for opioid use disorder) providers Credit Designations Available: Nursing CE Webinar description: This webinar will review variations on buprenorphine dosing that can be considered for patients with opioid use disorder involving fentanyl. The […]

  • Xylazine and How it Harms People Who Use Drugs

    Register now! Presenters: Raagini Jawa, MD Cost: No fee Target Audience: This activity was developed to meet the needs of physicians and all interprofessional healthcare providers. Description: We will review what is known to date on Xylazine, a CNS depressant, which has been linked to an increasing number of overdose deaths in the US. This […]

  • Opioid Use Disorder and Social Determinants of Health

    Presenters:   Rachel Talley, MD, Assistant Professor of Clinical Psychiatry/Director, Fellowship in Public and Community Psychiatry Jessica Isom, MD, Attending Psychiatrist, Codman Square Health Center/Clinical Instructor, Yale University/Faculty Lead, Social Justice and Health Equity Curriculum Sponsor: National Council for Mental Wellbeing--NCMW Continuing education information: Council for Mental Wellbeing will not be providing Continuing Medical Education […]

  • Changing the Default: Moving to an Opt-Out Approach for Treating Tobacco Use Disorders

    Join us on Wednesday, May 17th for the #VCBHLectureSeries as we welcome Kimber Richter, PhD, MPH, Professor of Population Health at the University of Kansas Medical Center. Dr. Richter will present "Changing the Default: Moving to an Opt-Out Approach for Treating Tobacco Use Disorders." Dr. Richter received her Master of Public Health from the University […]

  • Drug Use in Pregnancy (ASAM FAME Session 7)

    Register Now Questions about registering should be directed to: ASAM Education by email ateducation@asam.org Presenters: Abby Letcher, MD, FASAM Angela Colistra, PhD, LPC, CAADC, CCS Shanna Diaz, DO Leslie Hayes, MD Series: This 2-hour, virtual-live session is part of the FAME 8-session series and will cover overdose prevention and harm reduction. The FAME series is a facilitated, […]

  • Nurse Practitioners and Physician Assistants as Buprenorphine Providers: Facilitators and Barriers

    This presentation will describe the expansion of nurse practitioners and other advanced practice clinicians into opioid use disorder treatment, particularly in rural communities. It will also explore barriers and facilitators regarding nurse practitioner engagement in buprenorphine treatment, including regulations, education, and broader social factors such as stigma. Specific considerations for advanced practice clinicians' work with […]

  • Opioid Use Disorder in Pregnant and Postpartum People: The Treatment and Policy Landscape

    Register Now Presenters: Maria Manriquez, MD, FACOG, FASAM, PMH-C; Tara Sundem, APRN, NNP-BC; and Tawni Carson Sponsor: National Council for Mental Wellbeing--NCMW NOTE: The National Council for Mental Wellbeing will not be providing Continuing Medical Education for this event. Target Audience: This activity is designed for interprofessional teams, families and patients, students and educators, nurses, […]

  • Expanding Harm Reduction Access in the US for Rural and Other Underserved Populations

    This presentation will describe research around syringe service programs and methods of harm reduction distribution. Specific considerations for reaching members of rural communities will be discussed. Learning objectives: 1. Discuss the need for novel approaches for distributing harm reduction supplies 2. Describe benefits and challenges regarding syringe service programs 3. Outline specifics of programs that […]

  • A Qualitative Analysis of US State Laws Regulating Incentives for Health Behavior

    This presentation will describe the results of a qualitative study examining state laws regulating incentives for health behavior. Such laws may have important implications for provision of contingency management for substance use disorder, including in rural areas. Register and attend to learn more! Speaker: Barbara "Basia" Andraka-Christou, PhD, JD, Assistant Professor in the School of […]

  • Providing Comprehensive Care in Opioid Treatment Program: A Policy and Provider Perspective

    Presenters: Mark Parrino, President and CEO of The American Association for the Treatment of Opioid Dependence, Inc. Jennifer Seib, VP of Strategic Initiatives and Integration at BestSelf Behavioral Health Sponsor: National Council for Mental Wellbeing--NCMW Credit designational available: None Target Audience: Interprofessional teams, patients, educators, nurses, physicians, psychiatrists, psychologists, executives, clinical staff, administrators and social […]

  • Buprenorphine in the Age of Fentanyl: Discussing the New Guidance

    Presenter: John Mariani, MD Target Audience: This activity was developed to meet the needs of physicians and interprofessional healthcare providers. Discussion is designed to promote interactivity through an informal "round table" conversation. Attendees will be given the opportunity to speak directly with the presenter to ask questions and discuss issues. Register now

  • Reaching People Where They’re At: Smoking Cessation Treatment Delivery at Your Door

    This presentation will discuss novel ways to deliver evidence-based treatment for smoking cessation within and across rural areas. It will focus on 4 separate clinical trials of medication sampling, each demonstrating feasibility and efficacy of a simple yet novel treatment approach to reach a broad spectrum of smokers, including those who may not yet want […]

  • Clinical Primer and Discussion on Weekly and Monthly Injectable Buprenorphine

    Presenter: Michelle Lofwall, MD Target Audience: This activity was developed to meet the needs of physicians and interprofessional healthcare providers. Discussion is designed to promote interactivity through an informal "round table" conversation. Attendees will be given the opportunity to speak directly with the presenter to ask questions and discuss issues. Register now

  • Buprenorphine Dosing and Preparations in the Era of Fentanyl

    Presenters: Gail D’Onofrio, MD and Andrew Herring, MD Target Audience: This activity was developed to meet the needs of physicians and interprofessional healthcare providers. Discussion is designed to promote interactivity through an informal "round table" conversation. Attendees will be given the opportunity to speak directly with the presenter to ask questions and discuss issues. Register […]

  • Ready or Not Here Come the Nitazenes

    Presenter: Edwin Salsitz, MD Target Audience: This activity was developed to meet the needs of physicians and interprofessional healthcare providers. Discussion is designed to promote interactivity through an informal "round table" conversation. Attendees will be given the opportunity to speak directly with the presenter to ask questions and discuss issues. Register now

  • Women & Alcohol: What does stress have to do with it?

    Join us on Wednesday, November 15th for the #VCBHLectureSeries as we welcome Sherry McKee, PhD, Director, Yale Behavioral Pharmacology Laboratory. Dr. McKee will present "Women & Alcohol: What does stress have to do with it?" Dr. McKee directs a translational program of research focused on treatment development for addictive disorders, with an emphasis on women […]

  • Evidence-Based Treatment of PTSD in Individuals with OUD, and Innovative Approaches for Increasing Access to Care in Rural Communities

    This presentation will discuss effective treatment approaches for posttraumatic stress disorder (PTSD) in individuals with co-occurring opioid use disorder (OUD). It will also explore ways to increase access to evidence-based trauma treatment for members of rural communities. Register and attend to learn more! Speaker: Kelly Peck, PhD, Assistant Professor with joint appointments in the Departments of […]

  • The Changing World of Cannabis Consumption and Cannabis Regulation

    Vermont Center on Behavior and Health Monthly Lecture Series Alan Budney, PhD, Professor of Psychology, Geisel School of Medicine at Dartmouth Dr. Budney has conducted extensive research on the development and evaluation of innovative behavioral treatments for Cannabis Use Disorders in adults and adolescents. This programmatic research has focused on integrating innovative contingency management interventions […]

  • Collaborative Care Model (CoCM) for Substance Use Disorders

    Presenters: Anna Ratzliff, MD, PhD; Jasen Christensen, DO Webinar Description This presentation will review the Collaborative Care Model (CoCM), which is an evidence-based approach to delivering behavioral healthcare in primary care settings. This model has been adapted to address substance use disorders in primary medical settings. CoCM requires a team of providers; trained primary care […]

  • Overdose-related Compassion Fatigue in Rural Communities

    Erin Winstanley, PhD Visiting Professor, University of Pittsburgh School of Medicine Dr. Winstanley received her doctoral degree from The Johns Hopkins Bloomberg School of Public Health, she has postdoctoral training in behavioral pharmacology, and she has over 20 years of experience as a behavioral health services researcher. Dr. Winstanley's current research is focused on reducing […]

  • Treating Adolescents with Substance Use Disorder

    Presenter: Marc Fishman, MD Target Audience: This activity was developed to meet the needs of physicians and interprofessional healthcare providers. Discussion is designed to promote interactivity through an informal "round table" conversation. Attendees will be given the opportunity to speak directly with the presenter to ask questions and discuss issues. Register now

  • Improving Continuity of Care for Justice-Involved Individuals: Lessons from the Field

    Presenters: Ed Hayes, Assistant Superintendent at Franklin County Sheriff’s Office, Administrative Director of the FCSO OTP Rachel Katz, NP Director, Addiction Services, Friends of the Homeless (FOH), Medical Respite, CNP Sponsor: National Council for Mental Wellbeing--NCMW Credit designational available: none Target Audience: Administrative staff, counselors, interprofessional teams, psychologists, social workers About the webinar: Transitioning from […]

  • Engaging People Not Ready to Quit in Smoking Treatment: Evidence-Based Approaches

    Jessica Cook, PhD Professor, University of Wisconsin School of Medicine and Public Health Dr. Cook is a Professor at the University of Wisconsin School of Medicine and Public Health (UW-SMPH) and an investigator at the University of Wisconsin Center for Tobacco Research and Intervention (UW-CTRI). Dr. Cook is also a Clinician Investigator at the William […]

  • Northern New England ASAM Annual Conference

    Conference Agenda Day One: 5 PM – 6:30 PM:            Conference Check-in and Welcome Reception Refreshments and social hour. 6:30 PM – 7:30 PM:     […]

    $25 – $150

  • Northern New England ASAM Annual Conference

    Conference Agenda Day Two: 8:30 AM – 8:45 AM:    Welcome Remarks Clifton “Fred” Lord MD, President of NNESAM, ASAM Fellow, Board Certified in Addiction Medicine, CEO/Medical Director/Chairman of the […]

    $25 – $150

  • Telemedicine and Treating Opioid Use Disorder in Rural Populations

    Presenter: Greg Greenberg, MD Sponsor: American Academy of Addiction Psychiatry (AAAP) Cost: No Fee Target audience: This activity is designed for counselors, physician assistants, physicians, and psychiatrists. This activity is accredited for […]

  • Zeroing in on Xylazine

    Register now Description This training will provide knowledge regarding xylazine, a CNS depressant, which has been linked to an increasing number of overdose deaths in the US. This training will discuss […]

  • Essentials of Treating Stimulant Use Disorder

    Register now Description This training is a guide for addiction care teams caring for people who use stimulants,  including cocaine and methamphetamines. The training will review the basic science of […]

  • Essentials of Treating Stimulant Use Disorder

    Register now Description This training is a guide for addiction care teams caring for people who use stimulants,  including cocaine and methamphetamines. The training will review the basic science of […]

  • MA OBAT ECHO®: Treating Gambling Use Disorder

    Register now As part of the twice-monthly MA OBAT ECHO® series, Glimar Rodriguez, LADC-I, LICSW, MA PGS, will present the didactic entitled "Treating Gambling Use Disorder." The didactic will be […]

  • Zeroing in on Xylazine

    Register now Description This training will provide knowledge regarding xylazine, a CNS depressant, which has been linked to an increasing number of overdose deaths in the US. This training will discuss […]

  • Systemic Solutions for Managing Methamphetamine Use

    Register Now Presenter: Phillip Coffin, MD Sponsor: American Academy of Addiction Psychiatry (AAAP) Cost: No Fee Target audience: Interprofessional teams, nurses, pharmacists, PAs, physicians, social workers, students and educators, family and patient […]

  • Evaluating the Health Effects of Medicinal Cannabis Use

    Vermont Center on Behavior and Health Monthly Lecture Series Ryan Vandrey, PhD Professor of Psychiatry and Behavioral Sciences   Dr. Vandrey is currently a Professor at the Johns Hopkins University […]

  • Medications for Opioid Use Disorder in Carceral Settings: Issues and Effects

    Webinar

    University of Vermont Center on Behavior and Health Lecture Series David Farabee, Ph.D. Research Professor, Department of Population Health, NYU Grossman School of Medicine Professor Emeritus, University of California at Los Angeles   David Farabee, PhD is a Research Professor in the Department of Population Health at NYU Grossman School of Medicine. His research centers […]

  • The Quest for a Medication for Stimulant Use Disorder

    University of Vermont Center on Behavioral and Health MONTHLY LECTURE SERIES REGISTER FOR WEBINAR Craig Rush, Ph.D. Professor of Behavioral Science, Psychiatry, and Psychology College of Medicine, University of Kentucky   Craig R. Rush, PhD is a Professor of Behavioral Science at the University of Kentucky College of Medicine, with joint appointments in psychiatry and […]

  • Meeting Youth Where They Are: Substance Use Prevention and Treatment

    REGISTER NOW   ABOUT THE TRAINER: Dr. Laura Grubb, MD, MPH, FAAP is a board-certified pediatrician and adolescent medicine specialist with over 25 years of experience dedicated to advancing adolescent behavioral health through clinical care, public health leadership, and national advocacy. Her expertise centers on youth substance use prevention, treatment, and recovery, with a strong […]

  • From Risk to Resilience: Developmental Influences on Youth Substance Use and Mental Health

    REGISTER NOW ABOUT THE TRAINER: Dr. Laura Grubb, MD, MPH, FAAP is a board-certified pediatrician and adolescent medicine specialist with over 25 years of experience dedicated to advancing adolescent behavioral health through clinical care, public health leadership, and national advocacy. Her expertise centers on youth substance use prevention, treatment, and recovery, with a strong focus […]

  • Bringing Contingency Management to Scale: Key Steps for Public Health Impact

    University of Vermont Center on Behavior and Health Monthly Lecture Series Lara Coughlin, PhD, is an Associate Professor of Psychiatry at the University of Michigan Medical School and a licensed clinical psychologist specializing in addiction science. Her research focuses on developing and adapting evidence-based interventions—particularly contingency management and behavioral economic approaches—to improve treatment engagement and […]

  • Medication and Treatment for Cannabis Use Disorder

    Join Jonathan Fellers, MD, for a presentation that provides an overview of Cannabis Use Disorder and reviews medications that have been evaluated in clinical trials, including their proposed mechanisms, efficacy, and limitations. Participants will leave with a clearer understanding of current treatment options and greater confidence in discussing evidence-based approaches with patients. Learning Objectives: Identify […]

  • Gambling Below the Surface: Death by Suicide

    New England Addiction Technology Transfer Webinar Learn about the connection between problem gambling and death by suicide, including key risk factors such as financial strain, relationship challenges, and co-occurring alcohol use. Explore emerging data insights and practical implications to better inform prevention, data collection, and clinical support. Click to Register

  • Development of a Toolkit for Implementing Evidence-Based Assessment and Treatment Practices for Co-occurring PTSD and OUD in Rural Healthcare Settings

    This presentation will discuss evidence-based guidelines for the assessment and treatment of posttraumatic stress disorder (PTSD) in individuals with co-occurring substance use disorders (SUDs) as well as barriers and facilitators to implementation in rural medications for opioid use disorder (MOUD) treatment settings. It will also introduce the newly developed UVM CORA Co-occurring PTSD and OUD Toolkit. Presenters: Kelly […]

  • Targeting Tobacco Disparities: Innovative Cessation Strategies for Vulnerable Populations

    The Vermont Center on Behavior and Health Monthly Lecture Series Karen Cropsey, Psy.D. Professor of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham Karen L. Cropsey, Psy.D., is Professor and Vice Chair for Clinical Research in the Department of Psychiatry and Behavioral Neurobiology at the University of Alabama at Birmingham. She also holds the […]